MWNA
ACGN

Marshall Wace North America’s Aceragen Inc ACGN Stock Holding History

Marshall Wace North America’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-637
Closed -$96K – 1692
2018
Q3 		$96K Buy
+637
New +$91K ﹤0.01% 872
2018
Q1 		– Sell
-105
Closed -$30K – 1769
2017
Q4 		$30K Buy
+105
New +$30K ﹤0.01% 1331
2013
Q4 		$402K Buy
+638
New +$213K 0.01% 556

Other funds holding ACGN

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Marshall Wace North America's ACGN Position: Q4 2018 in Review

Marshall Wace North America sold out of Aceragen Inc (ACGN) in Q4 2018, closing a stake of 637 shares — an estimated $96K sold.

Marshall Wace North America first reported a position in ACGN in Q4 2013 and held it in 3 quarters. The position peaked at $402K in Q4 2013. 84 funds tracked by Wall St. Rank hold ACGN as of Q4 2018.

  • Marshall Wace North America reported no remaining Aceragen Inc position as of Q4 2018 after selling out during the quarter.
  • Marshall Wace North America sold 637 Aceragen Inc shares in Q4 2018, an estimated $96K.
  • Marshall Wace North America first reported a position in Aceragen Inc in Q4 2013 and held it in 3 quarters.
  • Marshall Wace North America's Aceragen Inc position peaked at $402K in Q4 2013.
  • 84 funds tracked by Wall St. Rank held Aceragen Inc as of Q4 2018.

Based on Marshall Wace North America's 13F filing for Q4 2018, filed 14 Feb 2019.